Combination therapy with extracorporeal photopheresis, interferon-α, PUVA and topical corticosteroids in the management of Sézary syndrome;Die Kombinationstherapie mit extrakorporaler Photopherese, Interferon-α, PUVA und lokalen Glukokortikoiden in der Behandlung des Sézary-Syndroms

JDDG - Journal of the German Society of Dermatology

Volumn 8, Issue 6, 2010, Pages 428-438

  Booken, Nina ^a   Weiß, Christel ^a   Utikal, Jochen ^a   Felcht, Moritz ^a   Goerdt, Sergij ^a   Klemke, Claus Detlev ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cutaneous T cell lymphoma; Extracorporeal photopheresis; Interferon ; PUVA; S zary syndrome; Therapy; Topical corticosteroids

Indexed keywords

BEXAROTENE; LACTATE DEHYDROGENASE; METHOTREXATE; RECOMBINANT GAMMA INTERFERON;

ADULT; AGED; ARTICLE; CD4 CD8 RATIO; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ERYTHRODERMA; FEMALE; HUMAN; LOW DRUG DOSE; MALE; PUVA; SEZARY SYNDROME; SURVIVAL TIME; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-ALPHA; MALE; MIDDLE AGED; PHOTOPHERESIS; PUVA THERAPY; SEZARY SYNDROME; TREATMENT OUTCOME;

EID: 77953164990     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2010.07319.x     Document Type: Article

References (43)

1. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpi-nelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJLM. WHO-EORTC classification for cutaneous lymphomas. Blood 2005 105 : 3768 3785.
2. Klemke CD, Mansmann U, Poenitz N, Dippel E, Goerdt S. Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sezary syndrome. Br J Dermatol 2005 153 : 118 124.
3. Vonderheid EC, Bernengo MG, Burg G, Duvic M, Heald P, Laroche L, Olsen E, Pittelkow M, Russell-Jones R, Taki-gawa M, Willemze R. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002 46 : 95 106.
4. Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, Zackheim H, Duvic M, Estrach T, Lamberg S, Wood G, Dummer R, Ranki A, Burg G, Heald P, Pittelkow M, Bernengo MG, Sterry W, Laroche L, Trautinger F, Whittaker S. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007 110 : 1713 1722. (Pubitemid 47443880)
5. Kaye FJ, Bunn PA Jr., Steinberg SM, Stocker JL, Ihde DC, Fischmann AB, Glatstein EJ, Schechter GP, Phelps RM, Foss FM. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 1989 321 : 1784 1790.
6. Stadler R, Assaf C, Klemke CD, Nashan D, Weichenthal M, Dummer R, Sterry W. Short German guidelines: cutaneous lymphomas. J Dtsch Dermatol Ges 2008 6 Suppl 1 : S25 S31.
7. Trautinger F, Knobler R, Willemze R, Peris K, Stadler R, Laroche L, D'Incan M, Ranki A, Pimpinelli N, Ortiz-Romero P, Dummer R, Estrach T, Whittaker S. EORTC consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome. Eur J Cancer 2006 42 : 1014 1030.
8. Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B, Vonderheid E, Knobler R, Wolff K, Plewig G et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med 1987 316 : 297 303.
9. Heald P, Rook A, Perez M, Wintroub B, Knobler R, Jegasothy B, Gasparro F, Berger C, Edelson R. Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol 1992 27 : 427 433.
10. Assaf C, Hummel M, Dippel E, Goerdt S, Muller HH, Anagnostopoulos I, Orfanos CE, Stein H. High detection rate of T-cell receptor beta chain rearrangements in T-cell lymphoproliferations by family specific polymerase chain reaction in combination with the GeneScan technique and DNA sequencing. Blood 2000 96 : 640 646.
11. Dippel E, Assaf C, Hummel M, Schrag HJ, Stein H, Goerdt S, Orfanos CE. Clonal T-cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: a critical evaluation. J Pathol 1999 188 : 146 154.
12. Klemke CD, Brade J, Weckesser S, Sachse MM, Booken N, Neumaier M, Goerdt S, Nebe TC. Diagnosis of blood involvement in Sézary Syndrome requires analysis of multiple markers by flow cytometry. Br J Dermatol 2008 159 : 871 880.
13. Zackheim HS, Koh HK, Weinstock MA. Assessing clinical outcomes in cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995 9 : 1021 1029.
14. Allison PD. Logistic regression using SAS system: Theory and Application.
15. Dippel E, Schrag H, Goerdt S, Orfanos CE. Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma. Lancet 1997 350 : 32 3.
16. Bisaccia E, Gonzalez J, Palangio M, Schwartz J, Klainer AS. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution. J Am Acad Dermatol 2000 43 : 263 271.
17. Wilson LD, Jones GW, Kim D, Rosenthal D, Christensen IR, Edelson RL, Heald PW, Kacinski BM. Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides. J Am Acad Dermatol 2000 43 : 54 60.
18. Richardson SK, Lin JH, Vittorio CC, Kim EJ, Yoon JS, Junkins-Hopkins J, Rook AH. High clinical response rate with multimodality immunomodulatory therapy for Sezary syndrome. Clin Lymphoma Myeloma 2006 7 : 226 232.
19. Scarisbrick JJ, Taylor P, Holtick U, Makar Y, Douglas K, Berlin G, Juvonen E, Marshall S. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease. Br J Dermatol 2008 158 : 659 678.
20. Prinz B, Behrens W, Holzle E, Plewig G. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma - the Dusseldorf and Munich experience. Arch Dermatol Res 1995 287 : 621 626.
21. Evans AV, Wood BP, Scarisbrick JJ, Fraser-Andrews EA, Chinn S, Dean A, Watkins P, Whittaker SJ, Russell-Jones R. Extracorporeal photopheresis in Sezary syndrome: hematologic parameters as predictors of response. Blood 2001 98 : 1298 1301.
22. Stevens SR, Baron ED, Masten S, Cooper KD. Circulating CD4+CD7- lymphocyte burden and rapidity of response: predictors of outcome in the treatment of Sezary syndrome and erythrodermic mycosis fungoides with extracorporeal photopheresis. Arch Dermatol 2002 138 : 1347 1350.
23. Rao V, Ryggen K, Aarhaug M, Dai HY, Jorstad S, Moen T. Extracorporeal photochemotherapy in patients with cutaneous T-cell lymphoma: is clinical response predictable? J Eur Acad Dermatol Venereol 2006 20 : 1100 1107.
24. Zic J, Arzubiaga C, Salhany KE, Parker RA, Wilson D, Stricklin GP, Greer J, King LE Jr. Extracorporeal photophe-resis for the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol 1992 27 : 729 736.
25. Koh HK, Davis BE, Meola T. Extracorporeal photopheresis for the treatment of 34 patients with cutaneous T-cell lymphoma. J Invest Dermatol 1994 102 : 567, Ref Type: Abstract.
26. Duvic M, Hester JP, Lemak NA. Photopheresis therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1996 35 : 573 579. (Pubitemid 26427060)
27. Gottlieb SL, Wolfe JT, Fox FE, DeNardo BJ, Macey WH, Bromley PG Lessin SR, Rook AH. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis mono-therapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution. J Am Acad Dermatol 1996 35 : 946 957.
28. Owsianowski M, Garbe C, Ramaker J, Orfanos CE, Gollnick H. [Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow-up and clinical outcome in 31 skin diseases]. Hautarzt 1996 47 : 114 123.
29. Stevens SR, Masten S, Oberhelman-Bragg LJ, Neckel SL, Cooper KD. Circulating CD4+/CD7- lymphocyte burden, CD4+/CD8+ ratio and rapidity of response are predictors of outcome in the treatment of CTCL with extracorporeal photochemotherapy (ECP). J Photoderm Photoimmunol Photomed 1996 12 : 36.
30. Zic JA, Stricklin GP, Greer JP, Kinney MC, Shyr Y, Wilson DC, King LE Jr. Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemo-therapy. J Am Acad Dermatol 1996 35 : 935 945.
31. Konstantinow A, Balda BR. Treatment of cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Eur Acad Dermatol Venereol 1997 9 : 111 117.
32. Russell-Jones R, Fraser-Andrews E, Spittle M, Whittaker S. Extracorporeal photopheresis in Sezary syndrome. Lancet 1997 350 : 886.
33. Vonderheid EC, Zhang Q, Lessin SR, Polansky M, Abrams JT, Bigler RD, Wasik MA. Use of serum soluble inter-leukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma. J Am Acad Dermatol 1998 38 : 207 220.
34. Zouboulis CC, Schmuth M, Doepfmer S, Dippel E, Orfanos CE. Extracorporeal photopheresis of cutaneous T-cell lymphoma is associated with reduction of peripheral CD4+ T lymphocytes. Dermatology 1998 196 : 305 308.
35. Jiang SB, Dietz SB, Kim M, Lim HW. Extracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7-year experience. Photodermatol Photoimmunol Photomed 1999 15 : 161 165.
36. Crovetti G, Carabelli A, Berti E, Guizzardi M, Fossati S, De Filippo C, Bertani E. Photopheresis in cutaneous T-cell lymphoma: five-year experience. Int J Artif Organs 2000 23 : 55 62.
37. Wollina U, Liebold K, Kaatz M, Looks A, Stuhlert A, Lange D. Survival of patients with cutaneous T-cell lymphoma after treatment with extracorporeal photochemotherapy. Oncol Rep 2000 7 : 1197 1201.
38. Wollina U, Liebold K, Kaatz M, Looks A, Stuhlert A, Lange D. Survival of patients with cutaneous T cell lymphoma after treatment with extracorporeal photochemotherapy: a retrospective single-center analysis. Ann N Y Acad Sci 2001 941 : 217 219.
39. Knobler E, Warmuth I, Cocco C, Miller B, Mackay J. Extracorporeal photo-chemotherapy - the Columbia Presbyterian experience. Photodermatol Photoimmunol Photomed 2002 18 : 232 237.
40. Suchin KR, Cucchiara AJ, Gottleib SL, Wolfe JT, DeNardo BJ, Macey WH, Bromley PG, Vittorio CC, Rook AH. Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution. Arch Dermatol 2002 138 : 1054 1060.
41. Quaglino P, Fierro MT, Rossotto GL, Savoia P, Bernengo MG. Treatment of advanced mycosis fungoides/Sezary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy. Br J Dermatol 2004 150 : 327 336.
42. de Misa RF, Harto A, Azana JM, Belmar P, Diez E, Ledo A. Photopheresis does not improve survival in Sezary syndrome patients with bone marrow involvement. J Am Acad Dermatol 2005 53 : 171 172.
43. Fraser-Andrews E, Seed P, Whittaker S, Russell-Jones R. Extracorporeal photopheresis in Sezary syndrome. No significant effect in the survival of 44 patients with a peripheral blood T-cell clone. Arch Dermatol 1998 134 : 1001 1005.